Cable Hill Partners’s Phibro Animal Health PAHC Stock Holding History

Cable Hill Partners’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-193	Closed	-$9K	–	839
2018 Q2	$9K	Hold	193	–	–	﹤0.01%	509
2018 Q1	$8K	Hold	193	–	–	﹤0.01%	545
2017 Q4	$7K	Hold	193	–	–	﹤0.01%	665
2017 Q3	$7K	Hold	193	–	–	﹤0.01%	681
2017 Q2	$7K	Buy	+193	New	+$6.3K	﹤0.01%	484

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Cable Hill Partners's PAHC Position: Q3 2018 in Review

Cable Hill Partners sold out of Phibro Animal Health (PAHC) in Q3 2018, closing a stake of 193 shares — an estimated $9K sold.

Cable Hill Partners first reported a position in PAHC in Q2 2017 and held it in 5 quarters. The position peaked at $9K in Q2 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q3 2018.

Cable Hill Partners reported no remaining Phibro Animal Health position as of Q3 2018 after selling out during the quarter.
Cable Hill Partners sold 193 Phibro Animal Health shares in Q3 2018, an estimated $9K.
Cable Hill Partners first reported a position in Phibro Animal Health in Q2 2017 and held it in 5 quarters.
Cable Hill Partners's Phibro Animal Health position peaked at $9K in Q2 2018.
191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2018.

Based on Cable Hill Partners's 13F filing for Q3 2018, filed 14 Nov 2018.